These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8933394

  • 1. Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine.
    Stewart TA, Nolan TM, Hogg G, McEwen J.
    J Paediatr Child Health; 1996 Oct; 32(5):378-81. PubMed ID: 8933394
    [Abstract] [Full Text] [Related]

  • 2. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.
    Robinson MJ, Heal C, Gardener E, Powell P, Sims DG.
    Pediatrics; 2004 Apr; 113(4):733-7. PubMed ID: 15060220
    [Abstract] [Full Text] [Related]

  • 3. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
    Avendano A, Ferreccio C, Lagos R, Horwitz I, Cayazzo M, Fritzell B, Meschievitz C, Levine M.
    Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775
    [Abstract] [Full Text] [Related]

  • 4. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J, Daft A, Samuelson J, Polin RA.
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [Abstract] [Full Text] [Related]

  • 5. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Apr; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 6. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Pourheidari F, Ostadkarampour M, Tavangar B, Shokri F.
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R.
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [Abstract] [Full Text] [Related]

  • 8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
    Richie E, Punjabi NH, Harjanto SJ, Wangsasaputral F, Sukandar M, Supriatman M, Simanjuntak CH, Que JU, Cryz SJ.
    Vaccine; 1999 Mar 17; 17(11-12):1384-93. PubMed ID: 10195774
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ.
    Southeast Asian J Trop Med Public Health; 1997 Mar 17; 28(1):91-8. PubMed ID: 9322290
    [Abstract] [Full Text] [Related]

  • 11. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005530. PubMed ID: 19588375
    [Abstract] [Full Text] [Related]

  • 12. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME, Corbel MJ, Redhead K, Ashworth LA, Begg NT.
    BMJ; 1991 Jun 22; 302(6791):1489-91. PubMed ID: 1855015
    [Abstract] [Full Text] [Related]

  • 13. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN, Maertens K, Dobly A, Leuridan E, Van Damme P, Huygen K.
    Virulence; 2017 Oct 03; 8(7):1245-1254. PubMed ID: 28277900
    [Abstract] [Full Text] [Related]

  • 14. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Käyhty H.
    Lancet; 2017 Oct 03; 348(9043):1688-92. PubMed ID: 8973430
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
    Martins Rde M, Camacho LA, Marcovistz R, Noronha TG, Maia Mde L, dos Santos EM, Barbosa GG, Silva AM, Souza PC, Lemos MC, Homma A.
    Mem Inst Oswaldo Cruz; 2008 Nov 03; 103(7):711-8. PubMed ID: 19057823
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.
    Mulholland EK, Ahonkhai VI, Greenwood AM, Jonas LC, Lukacs LJ, Mink CM, Staub JM, Todd J, Vella PP, Greenwood BM.
    Pediatr Infect Dis J; 1993 Aug 03; 12(8):632-7. PubMed ID: 8414774
    [Abstract] [Full Text] [Related]

  • 17. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ.
    Bull World Health Organ; 2000 Aug 03; 78(3):364-71. PubMed ID: 10812736
    [Abstract] [Full Text] [Related]

  • 18. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG.
    N Engl J Med; 1996 Feb 08; 334(6):341-8. PubMed ID: 8538704
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD.
    Pediatrics; 2000 Jan 08; 105(1):e11. PubMed ID: 10617748
    [Abstract] [Full Text] [Related]

  • 20. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain].
    González López A, Arístegui Fernández J, Díez-Delgado J, Dal-Ré Saavedra R.
    An Esp Pediatr; 1998 Feb 08; 48(2):132-7. PubMed ID: 9577019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.